daewoong pharma csp uk
Scope
Date
~
-
Korean food
Paris Baguette to showcase at London Franchise Show 2023
Paris Baguette, the bakery franchise owned by South Korea's SPC Group, said on Friday that it will participate in the London International Franchise...
Apr 07, 2023 (Gmt+09:00)
-
Batteries
LS Electric wins order $94 mn for energy storage system in UK
LS Electric Co. announced on Tuesday that it has secured a contract for a £73.6 million ($93.5 million) energy storage system (ESS) project in...
Apr 04, 2023 (Gmt+09:00)
-
Bio & Pharma
Lotte Biologics, Excellgene to collaborate on CDO biz
Lotte Biologics, South Korea's biopharmaceutical contract development and manufacturing organization (CDMO) company, announced on Sunday that it has...
Apr 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Kolon Pharma to merge with anti-cancer drug developer Platbio
Kolon Pharma, the pharmaceutical affiliate of South Korea's Kolon Group, is merging with anti-cancer drug developer Platbio to advance the developme...
Mar 30, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea's CJ Bioscience buys drug candidates from 4D pharma of the UK
South Korea’s pharmaceutical and healthcare company CJ Bioscience Inc. has acquired drug candidates from the UK's 4D pharma plc. to improve co...
Mar 27, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma receives 1st overseas patent for its hair loss treatment
JW Pharmaceutical, a drug company based in South Korea, has received its first patent for a hair loss treatment that is currently in development. Th...
Mar 27, 2023 (Gmt+09:00)
-
Future mobility
Kakao Mobility buys UK ride-hailing startup Splyt for global biz
South Korea’s Kakao Mobility Corp. said on Wednesday it has acquired the British ride-hailing startup Splyt, marking the first overseas takeov...
Mar 22, 2023 (Gmt+09:00)
-
Artificial intelligence
S.Korean startup Jobis&Villains expands to UK with tax return service
Jobis&Villains Corp., a South Korean startup that offers a tax return service called “3o3,” said on Friday that it had set up a loca...
Mar 17, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong wins approval for GERD treatment Fexuclu in Chile
South Korean pharmaceutical company Daewoong Pharmaceutical announced on Tuesday that it has received marketing authorization from Chile's National ...
Mar 14, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma to develop mRNA flu vaccine with Canadian pharma
South Korea's GC Biopharma Corp. announced on Thursday that it will start developing a flu vaccine based on messenger ribonucleic acid (mRNA).The dr...
Mar 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong’s Nabota expands into Germany, Austria
South Korean drugmaker Daewoong Pharmaceutical Co. said on Tuesday it had launched its botulinum toxin product Nabota in Germany and Austria through i...
Mar 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma's Fexuclue safe to use with aspirin: Clinical trials
Daewoong Pharmaceutical Co., a leading South Korean pharmaceutical company, has announced the successful completion of phase 1 clinical trials for...
Feb 28, 2023 (Gmt+09:00)
-
Bio & Pharma
Novel medicines poised to be Korea’s next mainstay export
South Korea, a major global generic and biosimilar medicine producer with leading names such as Samsung Biologics Co. and Celltrion Inc., has rapidl...
Feb 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea's Daewoong to export diabetes drug Envlo to Brazil, Mexico
South Korea’s Daewoong Pharmaceutical Co. said on Feb. 24 it is set to embark on global sales of Envlo, a new drug for diabetes, by exportin...
Feb 24, 2023 (Gmt+09:00)
-
Electric vehicles
SK Signet lands first order in UK worth $7.7 million
South Korea's SK Signet Inc., which produces ultra-fast chargers for electric vehicles (EVs), on Monday said its European branch SK Signet Europe in...
Feb 21, 2023 (Gmt+09:00)
-
Bio & Pharma
Korean court rules Daewoong poached Medytox’s botox strain
A South Korean court on Friday ruled in favor of Medytox Inc. in a civil lawsuit against its crosstown rival Daewoong Pharmaceutical Co. over the so...
Feb 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma wins permission from Singapore for Nabota
South Korea's drug development company Daewoong Pharmaceutical said on Thursday that it received on Jan. 20 product approval for its botulinum toxin...
Feb 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Medytox to sell off 2.2 mn shares of Daewoong's American partner Evolus
Medytox Inc. said in a regulatory filing on Wednesday that it is selling off approximately 2.19 million shares of Evolus, Daewoong Pharmaceutical's ...
Feb 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Coreline Soft to supply AI diagnosis solution to France
Coreline Soft, a South Korean company specializing in developing medical artificial intelligence (AI) devices, said on Tuesday that it has signed an...
Feb 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong receives approval for its GERD drug Fexuclue in Ecuador
Daewoong Pharmaceutical said Friday that it has obtained marketing authorization from Ecuador's National Agency for Health Regulation, Control and S...
Feb 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma's botulinum toxin Nabota proves long-lasting effect
Daewoong Pharmaceutical said on Friday that a high-dose administration of botulinum toxin Nabota (US brand name: Jeuveau) to patients with frown wri...
Feb 03, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
UK's Croda to buy Korean bio materials maker for $286 mn
Croda International Plc., a British specialty chemicals company, is set to acquire South Korean bio materials producer Solus Biotech Co. for some 35...
Feb 02, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Daewoong Pharmaceutical to export tech to British company
South Korea's Daewoong Pharmaceutical has licensed a new drug candidate for idiopathic pulmonary fibrosis (IPF) to CS Pharmaceuticals (CSP) of the U...
Feb 01, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma to put AI into new drug ingredient development
South Korea's drug developer JW Pharmaceutical is expanding the scope of its artificial intelligence (AI) uses from new drug research to the develop...
Jan 30, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea, Japan compete in gastroesophageal reflux drug market
South Korea is battling Japan again, this time on the global market to treat gastroesophageal reflux disease (GERD). South Korea's pharmaceutical pr...
Jan 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma's botulinum toxin Nabota wins approval from Australia
Daewoong Pharmaceutical said on Wednesday that its botulinum toxin formulation Nabota (overseas brand name: Nuceiva) won approval in Australia on Ja...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion increases its stake in British ADC developer Iksuda
Celltrion Inc. has secured an additional stake in the UK's antibody-drug conjugate (ADC) developer Iksuda Therapeutics.According to Celltrion on Wed...
Jan 25, 2023 (Gmt+09:00)
-
Automobiles
Hyundai, Kia make up 11.3% of UK's new car registrations in 2022
South Korean carmaker Hyundai Motor Group accounted for 11.3% of the new car registrations in the UK last year, according to a report that the Socie...
Jan 23, 2023 (Gmt+09:00)
-
Automobiles
Kia Sportage selected Family SUV of Year by UK auto journal
Kia Corp. said on Friday that its sport utility vehicle (SUV) Sportage has been named Family SUV of the Year by the British automotive magazine What...
Jan 20, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong accelerates investment in CDMO business
Daewoong, the holding company of South Korea's pharmaceutical-oriented Daewoong Group, is speeding up its pace to beef up its contract development a...
Jan 18, 2023 (Gmt+09:00)